KIT and breast carcinoma: More specifically, a marked decrease of TA was demonstrated in SK-N-MC cells (Ewing sarcoma cells), as well as other cell lines expressing c-kit including HSC 536/N (Fanconi anaemia cells), SK-MEL-28 (melanoma cells), RPMI 8226 (MM cells) and MCF-7 (breast cancer cells).